Canadian data is current through March 2018. All of the data comes from Health Canada, except for the categories Manufacturer Parent Company and Product Classification.
The Parent Company and the Product Classification were added by ICIJ.
The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Canada.
데이터 추가 비고
원인
Three subjects developed fistulae in the uk following treatment with the sonablate 500 for localized prostate cancer. all subjects had been previously treated for prostate cancer with brachytherapy with failure.